Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 13 (1) , 51-58
Abstract
Purpose: Non-melanoma skin cancers of the face are at high-risk for local recurrence and metastatic spread. While surgical interventions such as Mohs microsurgery are considered the standard of care, this modality has the potential for high rates of toxicity in sensitive areas of the face. Catheter flap high-dose-rate (HDR) brachytherapy has shown promising results, with high rates of local control and acceptable cosmetic outcomes. Material and methods: Patients with non-melanoma skin cancers (NMSC) located on the face were treated with 40 Gy in 8 fractions, given twice weekly via catheter flap HDR brachytherapy. Clinical target volume (CTV) included the visible tumor plus a margin of 5 mm in all directions, with no additional planning target volume (PTV) margin. Results: Fifty patients with 53 lesions on the face were included, with a median follow-up of 15 months. All were considered high-risk based on NCCN guidelines. Median tumor size and thickness were 18 mm and 5 mm, respectively. Median PTV volume and D-90 were 1.7 cc and 92%, respectively. Estimated rate of local control at twelve months was 92%. Three patients (5%) experienced acute grade 2 toxicity. Two patients (4%) continued to suffer from chronic grade 1 skin toxicity at 12 months post-radiotherapy (RT), with an additional two patients (4%) experiencing chronic grade 2 skin toxicity. Forty-nine lesions (92%) were found to have a good or excellent cosmetic outcome with complete tumor remission. Conclusions: CT-based flap applicator brachytherapy is a valid treatment option for patients with NMSC of the face. This modality offers high rates of local control with acceptable cosmetic outcomes and low rates of toxicity.Keywords
This publication has 56 references indexed in Scilit:
- Mohs resection and postoperative radiotherapy for head and neck cancers with incidental perineural invasionAmerican Journal of Otolaryngology, 2013
- Needs Assessment for Mohs Micrographic SurgeryDermatologic Clinics, 2012
- Retrospective Analysis of Local Control and Cosmetic Outcome of 147 Periorificial Carcinomas of the Face Treated With Low–Dose Rate Interstitial BrachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neckThe Laryngoscope, 2009
- Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-upThe Lancet Oncology, 2008
- Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomasJournal of the American Academy of Dermatology, 2005
- Interventions for basal cell carcinoma of the skin: systematic reviewBMJ, 2004
- Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lipJournal of the American Academy of Dermatology, 1992
- Dose-response curve and split-dose recovery in human skin cancerRadiotherapy and Oncology, 1984
- Mohs surgery. Technique, indications, applications, and the futureArchives of Dermatology, 1983